Speaker(s): 

Jessica Kozlosky MS, RDN, LDN, CDCES, Geisinger Staff Member - has nothing to disclose.

Moderator(s): 

Angela Marino, RDN, LDN, CDCES, Geisinger Staff Member - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the pathophysiology of DKA and HHS
• Discuss risk factors for and common precedents of DKA and HHS
• Discuss general protocols* for treatment of DKA and HHS
• Describe potential complications of DKA and HHS
• Discuss ways to prevent the development of DKA and HHS

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Stacy Coolbaugh, MBA, RDN, LDN; Angela Marino, RDN, LDN, CDCES; Adriene Zook, PharmD, RPH; David Mallarkey, BSN, RN, Jaime Ruiz, RN, BSN, and Joey Underhill have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose.

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None